The direct answer is to freeze the product identity before testing, connect every sample and report to that identity, and define what changes require a written reassessment before mass production. A high SPF result is useful only when the tested sample, formula, packaging, label claim and production specification can be traced to the same product version.
This question has become more relevant after the European Commission published results from a coordinated testing campaign on 15 September 2026. Market surveillance authorities from 11 EU countries selected 74 sunscreen products and day creams from shops and online channels. The campaign found a high correlation between an in vitro SPF method and the conventional in vivo method.
For brands sourcing private label sunscreen or sun care from China, the signal is encouraging. It also makes version control more important. A newer test method cannot correct a supply chain in which the report describes one sample while the commercial product follows another specification.
The European Commission reported that the in vitro method used in the campaign was EN ISO 23675:2024, published in December 2024. The method applies the sunscreen to two types of acrylic plates designed to represent skin texture. Product quantity, application, temperature and drying time are controlled, and a spectrophotometer measures the ultraviolet radiation passing through the sunscreen film.
The campaign compared the in vitro method with the conventional in vivo method and found a high level of correlation. The Commission described the in vitro approach as faster, less expensive and more ethical because it avoids exposing volunteers to ultraviolet radiation that causes erythema.
There are clear limits. The Commission states that the method cannot currently test sunscreen sticks or powders, and it does not cover water-resistance claims. The exact test plan therefore depends on product form, claims, destination market and the views of the responsible person, qualified laboratory and regulatory professional.
An SPF result belongs to a specific sample tested under a specific method. It does not automatically attach to every product that uses the same marketing name.
Changes in UV filter system, ingredient source, dispersion, viscosity, film formation, manufacturing process, dispensing package or directions for use may affect how the product performs. Some changes may require new testing. Others may support a documented technical assessment. The key is to define the decision process before a change occurs.
Buyers should also avoid treating one European test report as proof of global compliance. Sunscreen classification and permitted active ingredients differ by market. For example, Australia's Therapeutic Goods Administration opened a consultation on 11 September 2026 about possible additional controls for 4-methylbenzylidene camphor, or 4-MBC. The consultation is not a ban or recall, but it shows why the destination market should be defined before formula approval.
A practical version card should contain five connected sections.
Record the internal SKU, product form, intended user, destination country, sales platform and planned claims. A lotion, spray, stick and powder should not share an ambiguous product name in the project record.
Record the formula code, UV filter system, relevant raw-material lots, manufacturing date and production instruction. The card should identify the supplier document that defines the approved formula and process.
Assign the sample a batch or sample number. Record the number of units sent, photographs of the sealed sample, dispatch date, recipient laboratory and location of the retained sample.
Record the test method, SPF and UVA scope, laboratory, report number, report date and stated limitations. If a water-resistance claim or a format outside the method's scope is involved, document the additional method or rationale selected by the responsible experts.
Connect the approved formula to the package, dispensing method, label claim, directions for use and mass-production specification. The report, packaging artwork and purchase order should point back to the same version card.
The buyer and supplier should agree on change triggers before mass production. Typical triggers include:
A trigger does not always mean that the complete test programme must be repeated. It means the change must enter a documented assessment. The project record should name the decision maker, evidence reviewed, date and next action.
Use a three-way check before production approval: match the sample identifier, the sample description in the laboratory report and the final production specification to the same version card.
Then compare the formula code, manufacturing process, package, directions and label claims. If anything has changed, record the change and obtain the required technical or regulatory decision before shipment.
The European Commission notes that the responsible person ultimately remains responsible for ensuring that a sunscreen provides the protection stated on its label. A manufacturer or sourcing partner can organise samples, specifications and supporting files, but it cannot replace the responsible person's legal obligations or guarantee that one report is valid in every market.
Guangzhou Lianbiquan Biological Technology Co., Ltd., with Lanthome Skincare as its official website presence, is based in Guangzhou. Its public website presents face, hair, body and eye-care products and OEM/ODM services.
For a private label sunscreen or broader skincare project, Lanthome Skincare can help buyers organise candidate products and compare stock testing, small-batch options, light customisation, packaging and product combinations, or a full OEM/ODM route. During project coordination, it can also help structure a traceable checklist covering samples, specifications, packaging and production changes.
Exact formula availability, price, inventory, MOQ, lead time, test programme, compliance documents, overseas fulfilment and dropshipping options must be confirmed for the specific product, target country and current project conditions. Sunscreen testing and regulatory conclusions should be confirmed by qualified laboratories, the responsible person and relevant regulatory professionals.
Send your target country, sales platform, budget and expected quantity. Lanthome Skincare can help determine whether a stock-product test, light customisation or an OEM/ODM programme is the practical next step, and where testing should enter the version-control process.
